Galán, M, Almendra-Pegueros, R, Barros, AJ, Tabilo, JF, Dominguez-Tenreiro, M, Fernández, LM, Pérez-Marlasca, E, Borrás, N, Vidal, F, Martinez-González, J, Rodríguez, C. IDENTIFICATION OF NEW THERAPEUTIC TARGETS AND BIOMARKERS IN PATIENTS WITH ASCENDING AORTIC ANEURYSM ACCORDING WITH THEIR GENETIC HETEROGENEITY. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

Velasco, L, Querol, CB, Santos, D, Rotllan, N, Tondo, M, Camacho, M, Blanco-Vaca, F, Escolà-Gil, JC, Canyelles, M. IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

Grao-Cruces, E, Mocciaro, G, Marquez-Paradas, E, Santos-Mejias, A, Canyelles, M, Escola-Gil, JC, Martin-Rubio, ME, La Paz, SMD. HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

Vlacho, B, Iniesta, AM, Gratacòs, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Cos, FX, Franch-Nadal, J, Mauricio, D. Effectiveness of a multicomponent healthcare intervention on blood pressure and lipids among subjects with poorly controlled type 2 diabetes: Findings from the INTEGRA study. Primary Care Diabetes. 2024; 18(4)DOI:10.1016/j.pcd.2024.05.001. PMID:38782704. IF:2.300(Q2/5D).